figshare
Browse
13058_2016_691_MOESM5_ESM.doc (138.5 kB)

Additional file 5: Table S6. of Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer

Download (138.5 kB)
journal contribution
posted on 2016-03-15, 05:00 authored by Ian Krop, Shanu Modi, Patricia LoRusso, Mark Pegram, Ellie Guardino, Betsy Althaus, Dan Lu, Alexander Strasak, Anthony Elias
Summary of ORR by HER2 mRNA expression level as measured by quantitative reverse transcription polymerase chain reaction. (DOC 138 kb)

Funding

Genentech, Inc.

History

Usage metrics

    Breast Cancer Research

    Categories

    Keywords

    AdditionalORRpertuzumab6.transcription polymerase chain reactionPhaseHER 2-positive metastatic breast cancer SummaryDOC 138 kbtrastuzumab emtansineHER 2 mRNA expression levelpaclitaxelT-DM

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC